RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Amyloid-beta peptide is central to the pathology of Alzheimer's disease, because it is neurotoxic--directly by inducing oxidant stress, and indirectly by activating microglia. A specific cell-surface acceptor site that could focus its effects on target cells has been postulated but not identified. Here we present evidence that the 'receptor for advanced glycation end products' (RAGE) is such a receptor, and that it mediates effects of the peptide on neurons and microglia. Increased expressing of RAGE in Alzheimer's disease brain indicates that it is relevant to the pathogenesis of neuronal dysfunction and death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Yan et al. reported that Aβ peptides and Aβ oligomers can bind to RAGE receptor and activate glial cells.331”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [331]
In the citing paper
“Given that intracellular A β overload can induce oxidative stress and cell death [ 38-40 ]”
From Restores Aβ Clearance by Overcoming PCSK9–LRP1 Dysregulation and TRIB3‐Mediated Autophagy Blockade in Alzheimer's Disease (2026) · cites this paper as [38]
In the citing paper
“Enhancing A β uptake or efflux alone may increase intracellular A β -handling burden if autophagic degradation remains impaired [ 38-40 ].”
From Restores Aβ Clearance by Overcoming PCSK9–LRP1 Dysregulation and TRIB3‐Mediated Autophagy Blockade in Alzheimer's Disease (2026) · cites this paper as [38]
In the citing paper
“Apolipoprotein E3 (ApoE3), another key component of the lipoprotein‐like nanostructure, acts as an effective anti‐inflammatory molecule.[ 18 ]”
From Multifunctional Nanostructure RAP‐RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular Unit (2021) · cites this paper as [18]
In the citing paper
“In addition, a key component of RAP‐RL, ApoE3, has been shown to regulate pericyte‐mediated cerebrovascular integrity and anti‐inflammatory reaction.[ 18 , 19 ]”
From Multifunctional Nanostructure RAP‐RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular Unit (2021) · cites this paper as [18]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Osborn, L., Hession, C., Tizard, R., Vassallo, C., Luhowskyj, S., Chi-Rosso, G., & Lobb, R. (1989) · Cell · doi:10.1016/0092-8674(89)90775-7 · Cited by 1,689
Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., & Shaw, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,541
Self-citationNeurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Self-citationThe Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Self-citationHensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086
Research works printed but not linked: 4
- Haass, C. & Selkoe, D. Cell 7, 1039–1042 (1994).
- Trojanowski, J. & Lee, V. Am. J. Pathol. 144, 449–453 (1994).
- Gumkowski, F. et al. Blood Vessels 24, 11–18 (1987).
- Brett, J. et al. Am. J. Pathol. 143, 1699–1712 (1993).
Cited by
Items 701–800 of 1,027
RAGE Expression and AGE-Induced MAP Kinase Activation in Caco-2 Cells
Zill, H., Günther, R., Erbersdobler, H. F., Fölsch, U. R., & Faist, V. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5901 · Cited by 89
Cyclooxygenase-1 null mice show reduced neuroinflammation in response to β-amyloid
Choi, S.-H., & Bosetti, F. (2009) · Aging · doi:10.18632/aging.100021 · Cited by 84
Lubitz, I., Ricny, J., Atrakchi‐Baranes, D., Shemesh, C., Kravitz, E., Liraz‐Zaltsman, S., Maksin‐Matveev, A., Cooper, I., Leibowitz, A., Uribarri, J., et al. (2016) · Aging Cell · doi:10.1111/acel.12436 · Cited by 84
“Moreover, RAGE is increased in brains of AD patients, (Yan et al., 1996; Lue et al., 2001) and has a role in the regulation of Ab transport across the blood–brain barrier (BBB) (Lue et al., 2001; Askarova et al., 2011).”
BackgroundBertram, S., Brixius, K., & Brinkmann, C. K. (2016) · Endocrine · doi:10.1007/s12020-016-0976-8 · Cited by 94
Amylin deposition in the kidney of patients with diabetic nephropathy
Gong, W., Liu, Z., Zeng, C., Peng, A., Chen, H. P., Zhou, H., & Li, L. S. (2007) · Kidney International · doi:10.1038/sj.ki.5002305 · Cited by 87
Kato, J., & Svensson, C. I. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2014.11.014 · Cited by 92
Smith, L. M., Kostylev, M. A., Lee, S., & Strittmatter, S. M. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006252 · Cited by 73
Li, J., Qu, X., & Schmidt, A. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.30870 · Cited by 82
Self-citationComplement in Alzheimer's disease: opportunities for modulating protective and pathogenic events
Tenner, A. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00301-3 · Cited by 81
Overlapped Metabolic and Therapeutic Links between Alzheimer and Diabetes
Ahmad, W. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8352-z · Cited by 86
“in RAGE-bearing cells from AD patients when incubated with Aβ that resulted in increased oxidative stress through NADPH oxidase-like mechanism, and activated NF-κB pathway [161].”
BackgroundSchmidt, A. M. (2001) · Frontiers in Bioscience · doi:10.2741/a575 · Cited by 81
Self-citationHarris, S. E., Fox, H., Wright, A. F., Hayward, C., Starr, J. M., Whalley, L. J., & Deary, I. J. (2007) · BMC Genetics · doi:10.1186/1471-2156-8-43 · Cited by 81
Patel, V., & Edison, P. (2024) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2023-332661 · Cited by 80
Microglia and Synapse: Interactions in Health and Neurodegeneration
Šišková, Z., & Tremblay, M.-È. (2013) · Neural Plasticity · doi:10.1155/2013/425845 · Cited by 80
Sagare, A. P., Deane, R., Zetterberg, H., Wallin, A., Blennow, K., & Zlokovic, B. V. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101248 · Cited by 80
“Brain vasculature in AD expresses increased levels of RAGE [14, 43, 44] and reduced LRP levels [2, 16] associated with A cerebrovascular and/or brain accumulation.”
Ramasamy, R., & Schmidt, A. M. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-012-0089-5 · Cited by 80
Self-citationAbe, K., & Saitō, H. (1998) · Neuroscience Research · doi:10.1016/s0168-0102(98)00055-8 · Cited by 92
Price, J. M., Chi, X., Hellermann, G., & Sutton, E. T. (2001) · Neurological Research · doi:10.1179/016164101101198758 · Cited by 80
Meneghini, V., Bortolotto, V., Francese, M. T., Dellarole, A., Carraro, L., Terzieva, S., & Grilli, M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2052-12.2013 · Cited by 88
“…cell types, and, during ligand binding, it produces a sustained cellular activation, commonly regarded as deleterious because it participates in inflammation and cytotoxicity in both acute and chronic conditions (Yan et al., 1996; Schmitt et al., 2006; Muhammad et al., 2008; Han et al., 2011).”
BackgroundLeyton-Jaimes, M. F., Kahn, J., & Israelson, A. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.06.021 · Cited by 88
“AGE-related modification is present in early stages of AD and is known to contribute to its pathology (Yan et al., 1996; Donahue et al., 2006).”
RAGE binds preamyloid IAPP intermediates and mediates pancreatic β cell proteotoxicity
Abedini, A., Cao, P., Plesner, A., Zhang, J., He, M., Derk, J., Patil, S. A., Rosario, R., Lonier, J., Song, F., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci85210 · Cited by 90
Self-citationMechanisms Underlying Neuronal Death Induced by Chromogranin A-activated Microglia
Ciesielski-Treska, J., Ulrich, G., Chasserot-Golaz, S., Zwiller, J., Revel, M.-O., Aunis, D., & Bader, M.-F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009711200 · Cited by 80
Chrysamine-G, a lipophilic analogue of congo red, inhibits Aβ-induced toxicity in PC12 cells
Klunk, W. E., Debnath, M. L., Koros, A. M. C., & Pettegrew, J. W. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00454-8 · Cited by 85
Accumulation of modified proteins and aggregate formation in aging
Nowotny, K., Jung, T., Grune, T., & Höhn, A. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.05.016 · Cited by 89
“…for AGEs is RAGE (receptor for advanced glycation end products) (Schmidt et al., 1996), a multi-ligand receptor of the immunoglobulin superfamily, which is also able to bind agonists like S100 proteins (Hofmann et al., 1999), amyloid-β peptide (Yan et al., 1996) or amphoterin (Hori et al., 1995).”
BackgroundMorphological and Pathological Characteristics of Brain in Diabetic Encephalopathy
Chen, R., Shi, J., Yin, Q., Li, X., Sheng, Y., Han, J., Zhuang, P., & Zhang, Y. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180314 · Cited by 86
Mukherjee, T. K., Mukhopadhyay, S., & Hoidal, J. R. (2008) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2008.07.001 · Cited by 85
Biological Role of the N-Formyl Peptide Receptors
Panaro, M. A., Acquafredda, A., Sisto, M., Lisi, S., Maffione, A. B., & Mitolo, V. (2006) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923970600625975 · Cited by 86
Muscarinic m1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain
Müller, D., Mendla, K. D., Farber, S. A., & Nitsch, R. M. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00038-6 · Cited by 84
Tanaka, C., Kamata, H., Takeshita, H., Yagisawa, H., & Hirata, H. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6264 · Cited by 80
Jeon, M.-T., Kim, K.-S., Kim, E. S., Lee, S., Kim, J., Hoe, H.-S., & Kim, D.-G. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101333 · Cited by 76
“RAGE is upregulated in the brain endothelium in AD (Yan et al., 1996), and RAGE blockers or vasculoprotective agents attenuate the infiltration of circulating Aβ and Aβ deposit formation.”
BackgroundMicroglia as a critical player in both developmental and late-life CNS pathologies
Derecki, N. C., Katzmarski, N., Kipnis, J., & Meyer-Luehmann, M. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1321-z · Cited by 78
“Microglial activation elicited from the binding of Aβ to RAGe produced cytokines such as IL-1β and TNF-α, which in turn might lead to the clustering of microglia around Aβ plaques [76, 128].”
BackgroundMori, T., Koyama, N., Yokoo, T., Segawa, T., Maeda, M., Sawmiller, D., Tan, J., & Town, T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012330 · Cited by 77
Zen, K., Chen, C. X.-J., Chen, Y.-T., Wilton, R., & Liu, Y. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2483 · Cited by 78
Buhimschi, I. A., Zhao, G., Pettker, C. M., Bahtiyar, M. O., Magloire, L. K., Thung, S., Niven‐Fairchild, T., & Buhimschi, C. S. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.09.001 · Cited by 84
S100 proteins in cartilage: Role in arthritis
Yammani, R. R. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.01.006 · Cited by 92
The influence of cannabinoids on generic traits of neurodegeneration
Fagan, S. G., & Campbell, V. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12492 · Cited by 78
“The binding of PAMPs or DAMPS to pattern-recognition receptors, such as the Toll-like receptors (TLR) or receptors for advanced glycation end-products (RAGE), cause the migration of microglia followed by the synthesis and release of proinflammatory cytokines and reactive oxygen species (ROS) (Yan et al., 1996; Arroyo…”
BackgroundInfluentialIslet amyloid polypeptide: Another key molecule in Alzheimer’s pathogenesis?
Zhang, Y., & Song, W. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.001 · Cited by 83
“…erminal fragment, Ab: amyloid-b, tAb: truncated amyloid-b, BACE2: b-site APP- Endproducts (RAGE) generates oxidative stress and enhances the expression of macrophage-colony stimulating factor (M-CSF), which further precipitates the inflammatory pathways (Du Yan et al., 1997; Yan et al., 1996).”
BackgroundCui, Y., Le, Y., Yazawa, H., Gong, W., & Wang, J. M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.4.628 · Cited by 77
“glycation end products (RAGE) [32], both of which have been reported to bind A 42.”
BackgroundCardiovascular factors in Alzheimer's disease
STEWART, R. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.2.143 · Cited by 78
“It has been mentioned earlier that the increased risk of Alzheimer’s disease associated with type 2 diabetes may be mediated to a large extent by non-vascular mechanisms. These may include hyperglycaemia compounding the ischaemic burden of pre-existing vascular disease by increasing anaerobic metabolism and lactic aci…”
BackgroundHuang, Q., Jiang, C., Xia, X., Wang, Y., Yan, C., Wang, X., Lei, T., Yang, X., Yang, W., Cheng, G., et al. (2023) · Research · doi:10.34133/research.0180 · Cited by 78
Criscuolo, C., Fontebasso, V., Middei, S., Stazi, M., Ammassari-Teule, M., Yan, S. S., & Origlia, N. (2017) · Scientific Reports · doi:10.1038/srep42370 · Cited by 77
Self-citationEmerging roles of microglial cathepsins in neurodegenerative disease
Lowry, J. R., & Klegeris, A. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.02.014 · Cited by 86
Akhter, F., Chen, D., Akhter, A., Yan, S. F., & Yan, S. S. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.021 · Cited by 81
Self-citationXie, X., Liu, G., Niu, Y., Xu, C., Li, Y., Zhang, J., Jiao, X., Wang, X., & Tang, B. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03334 · Cited by 78
Chang, C.-H., Chen, C.-Y., Chiou, J.-Y., Peng, R. Y., & Peng, C.-H. (2010) · Journal of Medicinal Food · doi:10.1089/jmf.2009.1291 · Cited by 77
Untangling the role of amyloid in atherosclerosis
Howlett, G. J., & Moore, K. J. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000245260.63505.4f · Cited by 83
Walker, D., Lue, L. F., Paul, G., Patel, A., & Sabbagh, M. N. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1001490 · Cited by 77
Eun, S. Y., Ko, G. H., Park, S. W., Chang, K. C., & Kim, H. J. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.04.013 · Cited by 84
RAGE: A Novel Target for Drug Intervention in Diabetic Vascular Disease
Hudson, B. I., & Schmidt, A. M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000032992.75423.9b · Cited by 84
Self-citationLu, L., Pu, L. J., Zhang, Q., Wang, L. J., Kang, S., Zhang, R., Chen, Q., Wang, J. G., Caterina, R. D., & Shen, W. F. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.045 · Cited by 77
Endothelial Control of Cerebral Blood Flow
Ashby, J. W., & Mack, J. J. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.02.023 · Cited by 93
Immune Activation in Alzheimer Disease
Mary, A., Mancuso, R., & Heneka, M. T. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101921-035222 · Cited by 85
Creagh-Brown, B. C., Quinlan, G. J., Evans, T. W., & Burke-Gaffney, A. C. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1952-z · Cited by 78
Ding, Y., Qiao, A., & Fan, G.-H. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.022 · Cited by 75
“This scenario is consistent with previous studies showing that Aβ peptides directly induce synaptic loss and memory dysfunction (Knobloch and Mansuy, 2008) and that there is a correlation between learning deficit and Aβ plaques in a mouse model of AD (Yan et al., 1996).”
Review: NAD + : A modulator of immune functions
Grahnert, A., Grahnert, A., Klein, C., Schilling, E., Wehrhahn, J., & Hauschildt, S. (2011) · Innate Immunity · doi:10.1177/1753425910361989 · Cited by 76
Ruan, B. H., Li, X., Winkler, A. R., Cunningham, K. M., Kuai, J., Greco, R. M., Nocka, K. H., Fitz, L. J., Wright, J. F., Pittman, D. D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000863 · Cited by 83
“Characterized RAGE ligands include S100 proteins (1), HMGB1 (2), advanced glycation end products (AGEs) (3), the cell adhesion receptor MAC-1 (4), and amyloid-b peptide (5).”
BackgroundMisfolded Truncated Protein τ Induces Innate Immune Response via MAPK Pathway
Kovac, A., Zilka, N., Kazmerova, Z., Cente, M., Zilkova, M., & Novak, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100216 · Cited by 75
Prasansuklab, A., & Tencomnao, T. (2013) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2013/413808 · Cited by 75
RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease
Yan, S. S. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/265 · Cited by 75
Self-citationWang, D., Li, S., Zhu, X., Wang, Y., Wu, W., & Zhang, X. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1013-4 · Cited by 76
“Ab1–42 insult to neuronal cells has been identified as one of the major causes of AD [22, 23] and Ab25–35 has been reported as an active toxic fragment of Ab1–42 [24, 25].”
BackgroundReynolds, P. R., Kasteler, S. D., Schmitt, R. E., & Hoidal, J. R. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0231oc · Cited by 75
The importance of Ca2 Zn2 signaling S100 proteins and RAGE in translational medicine
Leclerc, E., & Heizmann, C. W. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/223 · Cited by 87
Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity
Teismann, P., Sathe, K., Bierhaus, A., Leng, L., Martin, H. L., Bucala, R., Weigle, B., Nawroth, P. P., & Schulz, J. B. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.12.006 · Cited by 75
“Rage-AGE interaction has been linked to the binding of amyloid fibers in Alzheimer's disease as well as propagating neurotoxic features of amyloid fibers (Yan et al., 1996).”
InfluentialSelf-citationCo-injection of β-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons
Morimoto, K., Yoshimi, K., Tonohiro, T., Yamada, N., Oda, T., & Kaneko, I. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00507-1 · Cited by 78
Kong, Y., Wang, F., Wang, J., Liu, C., Zhou, Y., Xu, Z., Zhang, C., Sun, B., & Guan, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00217 · Cited by 74
“Studies also have found that AGEs induce oxidative stress in neurons, promoting the release of neuroinflammatory cytokines and Aβ (Yan et al., 1996; Baig et al., 2018).”
BackgroundComplement System in Alzheimer’s Disease
Shah, A., Kishore, U., & Shastri, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413647 · Cited by 73
Cui, B., Li, K., Gai, Z., She, X., Zhang, N., Xu, C.-X., Chen, X., An, G., Ma, Q., & Wang, R. (2015) · Scientific Reports · doi:10.1038/srep12943 · Cited by 81
Self-citationCostantini, C., Rossi, F., Formaggio, E., Bernardoni, R., Cecconi, D., & Bianca, V. D. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:25:2:141 · Cited by 74
“…integrity (McLaurin and Chakrabartty, 1996), Aβ peptide binds to a variety of cell-surface receptors (Boland et al., 1996; El Khoury et al., 1996; Yan et al., 1996; Lorenzo et al., 2000; Wang et al., 2000; Kajkowski et al., 2001; Tiffany et al., 2001), including p75 neurotrophin receptor…”
BackgroundBrandenburg, L., Konrad, M., Wruck, C. J., Koch, T., Lucius, R., & Pufe, T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06637.x · Cited by 73
“Moreover, the advanced glycation end-product-specific receptor, receptor for advanced glycation endproducts (RAGE), which is expressed in neurons and microglia cells, in which it binds Ab1–42 with high affinity (Paresce et al. 1996; Yan et al. 1996; El Khoury et al. 1998).”
Backgroundα-Lipoic acid attenuates x-irradiation-induced oxidative stress in mice
Manda, K., Ueno, M., Moritake, T., & Anzai, K. (2006) · Cell Biology and Toxicology · doi:10.1007/s10565-006-0137-6 · Cited by 74
“Many studies suggest that oxidative stress is responsible for age-associated pathologies such as arteriosclerosis and neurodegenerative disorders (Yan et al., 1996; Goto et al., 1999; Butterfield and Kanski, 2001).”
BackgroundPark, S. A. (2011) · Journal of Clinical Neurology · doi:10.3988/jcn.2011.7.1.10 · Cited by 74
Walton, M. R., Gibbons, H., MacGibbon, G. A., Sirimanne, E., Saura, J., Gluckman, P. D., & Dragunow, M. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00262-3 · Cited by 73
“E-mail address: m.dragunow@auckland.ac.nz (M. Dragunow) Bitting et al., 1996; Yan et al., 1996).”
Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression
El‐Far, A. H., Sroga, G. E., Jaouni, S. K. A., & Mousa, S. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103613 · Cited by 77
Youn, K., Ho, C., & Jun, M. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2021.12.006 · Cited by 78
New Therapeutic Approaches for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Saito, S., & Ihara, M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00290 · Cited by 73
“Strong staining for RAGE has been reported in the vessels of AD patients (Yan et al., 1996; Donahue et al., 2006) and has been shown to mediate influx of circulating Aβ into brain across the BBB (Deane et al.”
BackgroundWhy Did Tarenflurbil Fail in Alzheimer's Disease?
Imbimbo, B. P. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1092 · Cited by 73
“Microglia express receptors that promote the clearance and phagocytosis of Aβ, such as class A scavenger receptor (CD36) [21] and receptor for advanced-glycosylation endproducts (RAGE) [22].”
Association between the RAGE G82S polymorphism and Alzheimer’s disease
Li, K., Dai, D., Zhao, B., Yao, L., Yao, S., Wang, B., & Yang, Z. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0334-6 · Cited by 79
Nygaard, H. B., & Strittmatter, S. M. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.223 · Cited by 73
Li, L., Wei, L. I., Jung, S., Lee, Y., & Kim, Y.-H. (2011) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.100606 · Cited by 77
The role of RAGE in the pathogenesis of intestinal barrier dysfunction after hemorrhagic shock
Raman, K. G., Sappington, P. L., Yang, R., Levy, R. M., Prince, J. M., Liu, S., Watkins, S. K., Schmidt, A. M., Billiar, T. R., & Fink, M. P. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00055.2006 · Cited by 73
Self-citationAdav, S. S., & Sze, S. K. (2016) · Molecular Brain · doi:10.1186/s13041-016-0272-9 · Cited by 70
Receptor for advanced glycation end-products in neurodegenerative diseases
Juranek, J., Ray, R., Banach, M., & Rai, V. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0003 · Cited by 73
Chemotactic-like receptors and Aβ peptide induced responses in Alzheimer's Disease
Lorton, D., Schaller, J., Lala, A., & Nardin, E. D. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00092-0 · Cited by 78
Innate Immunity in Alzheimer’s Disease: A Complex Affair
Guillot-Sestier, M.-V., & Town, T. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312050008 · Cited by 72
RAGE-TXNIP axis drives inflammation in Alzheimer’s by targeting Aβ to mitochondria in microglia
Sbai, O., Djelloul, M., Auletta, A., Ieraci, A., Vascotto, C., & Perrone, L. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04758-0 · Cited by 72
Janciauskiene, S. M., & Åhrén, B. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1989 · Cited by 76
Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer
Ohmori, H., Luo, Y., & Kuniyasu, H. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.546785 · Cited by 74
Glycated Serum Albumin and AGE Receptors
Vetter, S. W. (2015) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.07.005 · Cited by 79
RAGE and its ligands: from pathogenesis to therapeutics
Jangde, N., Ray, R., & Rai, V. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1819194 · Cited by 88
Protein Phosphorylation and APP Metabolism
Silva, E. F. D. C. E., & Silva, O. A. B. D. C. E. (2003) · Neurochemical Research · doi:10.1023/a:1025630627319 · Cited by 76
“Additionally, fibrillar A� can bind to receptors for advanced glycation end products (RAGE), thus inducing oxidative stress and possibly initiating an oxidative inflammatory response from activated microglia ( 60 ,61).”
Interaction of neurons and astrocytes underlies the mechanism of Aβ-induced neurotoxicity
Angelova, P. R., & Abramov, A. Y. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140153 · Cited by 71
Kuwahara, H., Nishina, K., Yoshida, K., Nishina, T., Yamamoto, M., Saito, Y., Piao, W., Yoshida, M., Mizusawa, H., & Yokota, T. (2011) · Molecular Therapy · doi:10.1038/mt.2011.186 · Cited by 71
Blanchard, B. J., Konopka, G., Russell, M., & Ingram, V. M. (1997) · Brain Research · doi:10.1016/s0006-8993(97)01003-2 · Cited by 75
Mechanisms of Neurodegenerative Disorders: Part 1: Protein Aggregates
Wolozin, B., & Behl, C. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.793 · Cited by 70
Heo, H.-J., Cho, H.-Y., Hong, B., Kim, H.-K., Kim, E.-K., Kim, B.-G., & Shin, D.-H. (2001) · Amyloid · doi:10.3109/13506120109007362 · Cited by 71
S100B causes apoptosis in a myoblast cell line in a RAGE‐independent manner
Sorci, G., Riuzzi, F., Agneletti, A. L., Marchetti, C., & Donato, R. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.10462 · Cited by 71
“…et al., 2001) and shown to transduce inflammatory stimuli and effects of neurotrophic and neurotoxic factors and to have a role in tumor growth (Hori et al., 1995; Yan et al., 1996; Hofmann et al., 1999; Huttunen et al., 1999, 2000; Taguchi et al., 2000; Lue et al., 2001; Wendt et al., 2002).”
BackgroundVitek, M. P., Snell, J., Dawson, H., & Colton, C. A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7408 · Cited by 71
Takeda, A., Yasuda, T., Miyata, T., Goto, Y., Wakai, M., Watanabe, M., Yasuda, Y., Horie, K., Inagaki, T., Doyu, M., et al. (1998) · Acta Neuropathologica · doi:10.1007/s004010050839 · Cited by 78
“Recently, Yan et al. [ 22 ] reported that the receptor for AGEs (RAGE) is also a specific cell surface acceptor site for A β and that RAGE elicits Aβ-mediated neurotoxicity to neuronal cells as well as microglial activation mediated by Aβ, suggesting the RAGE has a key role in the Aβ-mediated pathogenic”
Cellular Mechanisms for Amyloid β-Protein Activation of Rat Cholinergic Basal Forebrain Neurons
Jhamandas, J. H., Cho, C., Jassar, B., Harris, K., MacTavish, D., & Easaw, J. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.3.1312 · Cited by 71
“…identified, but its neurotoxic effects have been postulated to be mediated via plasma membrane receptors for advanced glycation end products (RAGE), class A scavenger receptor (SR)-related proteins, and/or the 75 kDa-neurotrophin receptor (El Khoury et al. 1996; Kuner et al. 1998; Yan et al. 1996).”
BackgroundBecher, B., Blain, M., & Antel, J. P. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00152-6 · Cited by 73
Metadata
- Authors
- Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D., & Schmidt, A. M.
- Affiliations
- Columbia University (US)
- University of Turin (IT)
- Heidelberg University (DE)
- Venue
- Nature
- Published
- 1996-08
- Volume
- 382
- Issue
- 6593
- Pages
- 685-691
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2049167261
- Cited by
- 2,012
- References
- 44
- Citations by year
- 2026: 28 · 2025: 33 · 2024: 44 · 2023: 46 · 2022: 56 · 2021: 48 · 2020: 59 · 2019: 58 · 2018: 65 · 2017: 55 · 2016: 77 · 2015: 75 · 2014: 81 · 2013: 93 · 2012: 100
- FWCI
- 58.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- receptor for advanced glycation end products, RAGE, amyloid-beta, neurotoxicity, Alzheimer's disease, microglial activation, oxidative stress, neuronal cell death, cell surface receptors, neuroinflammation
- MeSH terms
- Receptor for Advanced Glycation End Products, Alzheimer Disease, Animals, Base Sequence, Cattle, Cell Line, Cells, Cultured, Endothelium, Vascular, Humans, Molecular Sequence Data, Neurons, Receptors, Immunologic, Biomarkers, Amyloid beta-Peptides, PC12 Cells, Glycation End Products, Advanced, Microglia, DNA Primers, Oxidative Stress, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.